Web Summary
Q1: What is the name of the company and its origin?
A1: The company's name is Evergreen Pharma, and it was formed by a team of high-ranking veterans of the Pakistan Air Force who came together to provide world-class business consultancy, maintenance, and supply chain management services.
Q2: What is the industry in which the company operates?
A2: Evergreen Pharma operates in the pharmaceutical industry, specifically in the production and distribution of veterinary pharmaceuticals and feed additives for poultry and livestock.
Q3: What products does the company manufacture and distribute?
A3: The company manufactures and distributes a range of products, including Poultry Powder, Liquid Livestock Feed, Injectable Drench, Pencilline Powder, Feed Additives, Nutraceuticals, and Poultry & Livestock Feed.
Q4: What is the certification status of the company's products?
A4: Evergreen Pharma is a 1st national veterinary pharmaceutical certified company, holding ISO 9001:2015 and ISO 14001:2015 certifications by SGS. Its products are manufactured strictly conforming to WHO-cGMP and local regulatory requirements.
Q5: What is the address of the company's manufacturing facility?
A5: The company's manufacturing facility is located at 69-70/B, Main Glaxo Town Industrial Estate, 20 km Ferozpur Road, Lahore.
Q6: How can customers contact the company for inquiries or support?
A6: Customers can contact Evergreen Pharma through phone (042-35950523) or email (evergreen7862@yahoo.com). The company also has a working hours policy, with Monday to Saturday operations from 09 AM to 05 PM.
Q7: What is the purpose of the Maxicol solution product?
A7: Maxicol solution is an antibiotic powder used for treating infections caused by microorganisms susceptible to bacterial infections and secondary bacterial infections during viral diseases. It contains chlortetracycline HCl, which has broad-spectrum antibacterial and antiprotozoal activity.
Q8: What is the company's vision for 2025?
A8: Evergreen Pharma aims to accomplish its vision of 2025 by drafting a 5-year plan for indigenous manufacturing of automobile parts through technology transfer to Pakistan.